Carvedilol Tablet, Film Coated
Product Images NDC 70518-1826

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 70518-1826). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carvedilol 25mg 70518 1826 01

Carvedilol 25 mg film-coated tablets label showing quantity of 180 tablets. The label identifies RemedyRepack Inc. as the repackager and Zydus Pharm, Pennington, NJ, as the manufacturer. Includes NDC 70518-1826-01 and directions to see package insert for use instructions, storing temperature, and a warning to keep medication out of reach of children.*

FDA Label Image

Carvedilol 25mg 70518 1826 02

Carvedilol 25 mg film-coated tablets label showing quantity of 90 tablets. The label includes the NDC number 70518-1826-02 and repackaging details by RemedyRepack Inc., Indiana, PA. Manufacturer is Zydus Pharm, Pennington, NJ. Directions refer to package insert. Warning to keep medication out of the reach of children is visible.*

FDA Label Image

Remedy_label (Remedy Label)

Carvedilol 25 mg film-coated tablets, quantity 30, repackaged by RemedyRepack Inc. The label includes standard prescription drug warnings, storage instructions, and manufacturer information from Zydus Pharm, Pennington, NJ. The package is designated for RX use only and advises consulting the package insert for directions.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)

Chemical structure of Carvedilol, showing its molecular bonds and connected functional groups including an indole moiety and a methoxy-substituted phenyl group.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)

A line graph comparing the percentage mortality over time (in months) between Carvedilol and placebo groups. The graph shows mortality rising over about 21 months, with lower mortality rates in the Carvedilol group compared to placebo, supported by a reported p-value of 0.0014 indicating statistical significance.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)

A forest plot displaying hazard ratios with confidence intervals for subgroups including gender (men, women), age (<65, ≥65), race (non-black, black), diabetic status, ischemic status, heart rate, systolic blood pressure (SBP), spironolactone use, and all patients combined. The horizontal axis represents the hazard ratio scale from 0.0 to 2.0.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)

A line graph comparing mortality percentages over 24 months between groups labeled as Placebo and Carvedilol. The x-axis represents time in months, and the y-axis shows percentage mortality. The graph includes a p-value of 0.03, indicating statistical comparison between the two groups.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)

A forest plot displaying hazard ratios with confidence intervals for various patient subgroups and clinical variables in two panels. The charts compare cardiovascular outcomes such as post-myocardial infarction timing, beta-blocker use, Killip class, and other medical conditions like diabetes, hypertension, and heart rate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.